Published online 2 February 2004
Nucleic Acids Research, 2004, Vol. 32, No. 2 719-727
© 2004 Oxford University Press
A new
-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase
The Skaggs Institute for Chemical Biology and the Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, BCC-379, La Jolla, CA 92037, USA
*To whom correspondence should be addressed. Tel: +1 858 784 8970; Fax: +1 858 784 8990; Email: schimmel{at}scripps.edu
Two forms of human tryptophanyl-tRNA synthetase (TrpRS) are produced in vivo through alternative mRNA splicing. The two forms, full-length TrpRS and mini TrpRS, are catalytically active, but are distinguished by the striking anti-proliferative and anti-angiogenic activity specific to mini TrpRS. Here we describe two new splice variants of human TrpRS mRNA. Their production was strongly regulated by
-interferon (IFN-
), an anti-proliferative cytokine known to stimulate the expression of other anti-angiogenic factors. A new IFN-
-sensitive promoter was demonstrated to drive production of these splice variants. In human endothelial cells, both the newly discovered and a previously reported promoter were shown to respond specifically to IFN-
and not to other cytokines such as tumor necrosis factor-
, transforming growth factor-ß, interleukin-4 or erythropoietin. In addition, both promoters were stimulated by the downstream interferon regulatory factor 1 that, in turn, is known to be regulated by the upstream signal transducer and activator of transcription 1
subunit. Thus, the tandem promoters provide a dual system to regulate expression and alternative splicing of human TrpRS in vivo.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. G. Park, P. Schimmel, and S. Kim Aminoacyl tRNA synthetases and their connections to disease PNAS, August 12, 2008; 105(32): 11043 - 11049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kapoor, Q. Zhou, F. Otero, C. A. Myers, A. Bates, R. Belani, J. Liu, J.-K. Luo, E. Tzima, D.-E. Zhang, et al. Evidence for Annexin II-S100A10 Complex and Plasmin in Mobilization of Cytokine Activity of Human TrpRS J. Biol. Chem., January 25, 2008; 283(4): 2070 - 2077. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Mehler and J. S. Mattick Noncoding RNAs and RNA Editing in Brain Development, Functional Diversification, and Neurological Disease Physiol Rev, July 1, 2007; 87(3): 799 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Wieland and F. V. Chisari Stealth and Cunning: Hepatitis B and Hepatitis C Viruses J. Virol., August 1, 2005; 79(15): 9369 - 9380. [Full Text] [PDF] |
||||
![]() |
S. G. Park, H. J. Kim, Y. H. Min, E.-C. Choi, Y. K. Shin, B.-J. Park, S. W. Lee, and S. Kim From The Cover: Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response PNAS, May 3, 2005; 102(18): 6356 - 6361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wieland, R. Thimme, R. H. Purcell, and F. V. Chisari Genomic analysis of the host response to hepatitis B virus infection PNAS, April 27, 2004; 101(17): 6669 - 6674. [Abstract] [Full Text] [PDF] |
||||



